FI64899B - Foerfarande foer framstaellning av mikrosfaerer bestaoende av en polymer och ett kaernmaterial - Google Patents

Foerfarande foer framstaellning av mikrosfaerer bestaoende av en polymer och ett kaernmaterial Download PDF

Info

Publication number
FI64899B
FI64899B FI782501A FI782501A FI64899B FI 64899 B FI64899 B FI 64899B FI 782501 A FI782501 A FI 782501A FI 782501 A FI782501 A FI 782501A FI 64899 B FI64899 B FI 64899B
Authority
FI
Finland
Prior art keywords
polymer
core material
solvent
microcapsules
isopropanol
Prior art date
Application number
FI782501A
Other languages
English (en)
Finnish (fi)
Other versions
FI64899C (fi
FI782501A (fi
Inventor
Jones Wing Fong
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of FI782501A publication Critical patent/FI782501A/fi
Application granted granted Critical
Publication of FI64899B publication Critical patent/FI64899B/fi
Publication of FI64899C publication Critical patent/FI64899C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/26—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests in coated particulate form
    • A01N25/28—Microcapsules or nanocapsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0241—Containing particulates characterized by their shape and/or structure
    • A61K8/025—Explicitly spheroidal or spherical shape
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/85—Polyesters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q13/00—Formulations or additives for perfume preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02—Making microcapsules or microballoons
    • B01J13/06—Making microcapsules or microballoons by phase separation
    • B01J13/08—Simple coacervation, i.e. addition of highly hydrophilic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/56—Compounds, absorbed onto or entrapped into a solid carrier, e.g. encapsulated perfumes, inclusion compounds, sustained release forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/60—Particulates further characterized by their structure or composition
    • A61K2800/61—Surface treated
    • A61K2800/62—Coated
    • A61K2800/624—Coated by macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/60—Particulates further characterized by their structure or composition
    • A61K2800/65—Characterized by the composition of the particulate/core
    • A61K2800/654—The particulate/core comprising macromolecular material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Birds (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dispersion Chemistry (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)

Claims (13)

1. Förfarande för framställning av mikrosfärer bestäende av en polymer och ett kärnmaterial genom att sätta ett fasseparerings-medel tili ett medium bestäende av en lösning av polymeren och en dispersion eller lösning av kärnmaterialet och genom att härda vid en temperatur under -40°C, kännetecknat därav, att även fassepareringen sker vid en lag temperatur mellan -40°C och -100°C.
2. Förfarande enligt patentkravet 1,kännetecknat därav, att man framställer mikrokapslar omfattande en polymerbelägg-ning, sora omger en fast kärnmaterialkropp, genom att sätta ett fas-separeringsmedel tili ett medium bestäende av en dispersion av kärnmaterialets mikropartiklar i en lösning av polymeren.
3. Förfarande enligt patentkravet 1,kännetecknat därav, att man framställer mikropärlor bestäende av en homogen blandning av en polymer och ett kärnmaterial genom att sätta ett fassepareringsmedel tili en gemensam lösning av polymeren och kärnmaterialet.
4. Förfarande enligt nägot av föregäende patentkrav, kännetecknat därav, att kärnmaterialet är ett läke-medel.
5. Förfarande enligt nägot av föregäende patentkrav, kännetecknat därav, att kärnmaterialet omfattar för-formade mikrosfärer.
6. Förfarande enligt patentkravet 4,kännetecknat därav, att polymeren är en biologiskt sönderdelbar polymer.
7. Förfarande enligt patentkravet 6, kännetecknat därav, att polymeren är en polymjölksyra, polyglykolsyra, poly-hydroxismörsyra eller deras sampolymerer.
FI782501A 1977-08-25 1978-08-16 Foerfarande foer framstaellning av mikrosfaerer bestaoende av en polymer och ett kaernmaterial FI64899C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82771077A 1977-08-25 1977-08-25
US82771077 1977-08-25

Publications (3)

Publication Number Publication Date
FI782501A FI782501A (fi) 1979-02-26
FI64899B true FI64899B (fi) 1983-10-31
FI64899C FI64899C (fi) 1984-02-10

Family

ID=25249947

Family Applications (1)

Application Number Title Priority Date Filing Date
FI782501A FI64899C (fi) 1977-08-25 1978-08-16 Foerfarande foer framstaellning av mikrosfaerer bestaoende av en polymer och ett kaernmaterial

Country Status (21)

Country Link
JP (1) JPS5455717A (sv)
AT (1) AT372019B (sv)
AU (1) AU522215B2 (sv)
BE (1) BE869915A (sv)
CA (1) CA1122077A (sv)
CH (2) CH644768A5 (sv)
DE (1) DE2836044A1 (sv)
DK (2) DK361878A (sv)
ES (1) ES472800A1 (sv)
FI (1) FI64899C (sv)
FR (1) FR2400950A1 (sv)
GB (1) GB2003108B (sv)
IE (1) IE47255B1 (sv)
IL (1) IL55418A (sv)
IT (1) IT1098111B (sv)
NL (1) NL7808613A (sv)
NZ (1) NZ188232A (sv)
PH (1) PH15447A (sv)
PT (1) PT68473A (sv)
SE (1) SE431942B (sv)
ZA (1) ZA784855B (sv)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6045845B2 (ja) * 1979-10-31 1985-10-12 田辺製薬株式会社 医薬物質含有マイクロカプセルの製法
US4384975A (en) * 1980-06-13 1983-05-24 Sandoz, Inc. Process for preparation of microspheres
PH19942A (en) * 1980-11-18 1986-08-14 Sintex Inc Microencapsulation of water soluble polypeptides
DE3045135A1 (de) * 1980-11-29 1982-06-09 Sandoz-Patent-GmbH, 7850 Lörrach Pharmazeutische kompositionen enthaltende bioabbaubare polymere
JPS5933214A (ja) * 1982-08-19 1984-02-23 Mitsui Toatsu Chem Inc 微小球に製剤された制ガン剤の製造方法
AT382076B (de) * 1982-10-15 1987-01-12 Chemie Linz Ag Verfahren zur herstellung von presslingen mit retardierter wirkstofffreisetzung
DE3417576A1 (de) * 1984-05-11 1985-11-14 Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München Retardformen des alpha-(2,5-dimethoxy-phenyl)-ss-glycinamidoaethanols und verfahren zu ihrer herstellung
DE3428372A1 (de) * 1984-08-01 1986-02-13 Hoechst Ag, 6230 Frankfurt Mikrokapseln von regulatorischen peptiden mit kontrollierter freisetzung, verfahren zu ihrer herstellung und injektionszubereitungen
CH660302A5 (fr) * 1984-10-17 1987-04-15 Debiopharm Sa Procede de micro-encapsulation en phase heterogene de substances medicamenteuses hydrosolubles.
CH669506A5 (en) * 1986-01-13 1989-03-31 Hugo Degen Oscillating and reclining furniture
DE3712095A1 (de) * 1987-04-10 1988-10-20 Lentia Gmbh Bindemittelfreies granulat mit verzoegerter wirkstoffabgabe
US4861627A (en) * 1987-05-01 1989-08-29 Massachusetts Institute Of Technology Preparation of multiwall polymeric microcapsules
HU221294B1 (en) * 1989-07-07 2002-09-28 Novartis Ag Process for producing retarde compositions containing the active ingredient in a polymeric carrier
FR2657255B1 (fr) * 1989-12-27 1992-04-24 Sederma Sa Description de preparations cosmetiques originales dont les principes actifs sont pieges dans un reseau polymerique greffe a la surface de particules de silice.
DE4127757A1 (de) * 1991-02-06 1992-08-13 Hoechst Ag Neue pflanzenschutzmittel-formulierungen
US6204308B1 (en) 1999-03-01 2001-03-20 Novartis Ag Organic compounds
DE60121170T2 (de) 2000-05-12 2007-05-16 Matregen Corp., Toronto Verfahren zur herstellung von strukturen durch gebrauch von zentrifugalen kräften
US6969480B2 (en) 2000-05-12 2005-11-29 Matregen Corp. Method of producing structures using centrifugal forces
US6824822B2 (en) * 2001-08-31 2004-11-30 Alkermes Controlled Therapeutics Inc. Ii Residual solvent extraction method and microparticles produced thereby
US20110027376A1 (en) * 2007-12-11 2011-02-03 Nanyang Technological University Hollow Multi-Layered Microspheres for Delivery of Hydrophilic Active Compounds
US8574669B2 (en) 2008-05-21 2013-11-05 Toray Industries, Inc. Method for producing polymer fine particle comprising contacting an emulsion with a poor solvent
CN103828801B (zh) * 2014-01-15 2016-01-27 福建农林大学 多杀菌素/甲氨基阿维菌素苯甲酸盐微球及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT631615A (sv) * 1960-02-26
US3427250A (en) * 1963-03-25 1969-02-11 Polaroid Corp Microscopic capsules and process for their preparation
US3531418A (en) * 1965-08-18 1970-09-29 Ncr Co En masse encapsulation process
FR1497584A (fr) * 1966-08-11 1967-10-13 Roussel Uclaf Procédé de fabrication de microcapsules
US3703474A (en) * 1967-08-21 1972-11-21 Ncr Co Encapsulation process
US3773919A (en) * 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
JPS51125675A (en) * 1975-02-13 1976-11-02 Asahi Chem Ind Co Ltd A porous capsule structvre and a process for manufacturing turing it

Also Published As

Publication number Publication date
IL55418A (en) 1981-07-31
IT1098111B (it) 1985-09-07
IT7826961A0 (it) 1978-08-23
IE47255B1 (en) 1984-02-08
FI64899C (fi) 1984-02-10
GB2003108B (en) 1982-03-24
CH644768A5 (de) 1984-08-31
SE431942B (sv) 1984-03-12
ES472800A1 (es) 1979-10-16
ATA612478A (de) 1983-01-15
JPS645005B2 (sv) 1989-01-27
PT68473A (fr) 1978-09-01
NL7808613A (nl) 1979-02-27
GB2003108A (en) 1979-03-07
AT372019B (de) 1983-08-25
FR2400950A1 (fr) 1979-03-23
DK361878A (da) 1979-02-26
DE2836044C2 (sv) 1988-06-23
IL55418A0 (en) 1978-10-31
SE7808759L (sv) 1979-02-26
PH15447A (en) 1983-01-18
DK618189D0 (da) 1989-12-07
IE781708L (en) 1979-02-25
AU522215B2 (en) 1982-05-20
FI782501A (fi) 1979-02-26
CA1122077A (en) 1982-04-20
DE2836044A1 (de) 1979-03-01
ZA784855B (en) 1980-04-30
FR2400950B1 (sv) 1983-10-07
BE869915A (fr) 1979-02-23
CH649217A5 (de) 1985-05-15
NZ188232A (en) 1980-12-19
AU3923678A (en) 1980-02-28
JPS5455717A (en) 1979-05-04
DK618189A (da) 1989-12-07

Similar Documents

Publication Publication Date Title
FI64899B (fi) Foerfarande foer framstaellning av mikrosfaerer bestaoende av en polymer och ett kaernmaterial
US4166800A (en) Processes for preparation of microspheres
Khandbahale Microencapsulation-A novel approach in drug delivery: a review
Singh et al. Microencapsulation: A promising technique for controlled drug delivery
CN107028894B (zh) 一种载药微球及其制备方法和应用
US6120787A (en) Sustained release particles
CN101940554B (zh) 一种用于负载水溶性小分子药物的多核芯粘附微球及其制备方法
Dhakar et al. Variables influencing the drug entrapment efficiency of microspheres: A pharmaceutical review
KR860001561B1 (ko) 마이크로 캪슐과 그 제조방법
JP2000511110A (ja) 超臨界流体を使用したマイクロカプセル化方法
JPH02504025A (ja) 多壁ポリマーマイクロカプセルの調整
WO2002049619A9 (en) Induced phase transition method for the production of microparticles containing hydrophilic active agents
Kondo et al. Preparation of sustained-release coated particles by novel microencapsulation method using three-fluid nozzle spray drying technique
JP3179132B2 (ja) 非粘着性皮膜形成法
Jelvehgari et al. Preparation and determination of drug-polymer interaction and in-vitro release of mefenamic acid microspheres made of celluloseacetate phthalate and/or ethylcellulose polymers
Riekes et al. Development and evaluation of poly (3-hydroxybutyrate-co-3-hydroxyvalerate) and polycaprolactone microparticles of nimodipine
JP2013509287A (ja) 同軸ノズルを使用した１−ｋ系のための反応性成分のカプセル化
Krishna et al. A review on microsphere for novel drug delivery system
Fetih Formulation and characterization of Gelucire pellets for sustained release of Ibuprofen
JPH0372097B2 (sv)
Singh et al. Sustained drug delivery using mucoadhesive microspheres: the basic concept, preparation methods and recent patents
Ratnaparkhi et al. Mucoadhesive microsphere-review
KR102181231B1 (ko) 로티고틴 함유 고분자 미립자의 제조방법
WO2020145752A2 (ko) 레티노익산을 포함하는 미립구형 서방출 제제 및 그의 제조방법
Mohapatra et al. EFFECT OF PREPARATION TEMPERATURE ON ETHYLCELLULOSE MICROSPHERE PROPERTIES PREPARED BY OIL-IN-OIL EMULSION SOLVENT EVAPORATION PROCESS.

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: SANDOZ AG